Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 556 AL 570

Neuroprotective Strategies for Neurological Disorders by Natural Products: An update

Rehman MU, Wali AF, Ahmad A, Shakeel S, Rasool S, Ali R, Rashid SM, Madkhali H, Ganaie MA, Khan R.

Curr Neuropharmacol. 2019;17(3):247-267. doi: 10.2174/1570159X16666180911124605.

Astragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic Review

Costa IM, Lima FOV, Fernandes LCB, Norrara B, Neta FI, Alves RD, Cavalcanti JRLP, Lucena EES, Cavalcante JS, Rego ACM, Filho IA, Queiroz DB, Freire MAM, Guzen FP.

Curr Neuropharmacol. 2019;17(7):648-665. doi: 10.2174/1570159X16666180911123341.

Multisystem Balance Training Reduces Injurious Fall Risk in Parkinson Disease: A Randomized Trial

Wong-Yu ISK, Mak MKY.

Am J Phys Med Rehabil. 2019 Mar;98(3):239-244. doi: 10.1097/PHM.0000000000001035.

Classic animal models of Parkinson's disease: a historical perspective

Hamadjida A, Frouni I, Kwan C, Huot P.

Behav Pharmacol. 2019 Jun;30(4):291-310. doi: 10.1097/FBP.0000000000000441.

Neural correlates of apathy in patients with neurodegenerative disorders: an activation likelihood estimation (ALE) meta-analysis

Raimo S, Santangelo G, D'Iorio A, Trojano L, Grossi D.

Brain Imaging Behav. 2019 Dec;13(6):1815-1834. doi: 10.1007/s11682-018-9959-0.

Food Components with the Potential to be Used in the Therapeutic Approach of Mental Diseases

Fernández MJF, Valero-Cases E, Rincon-Frutos L.

Curr Pharm Biotechnol. 2019;20(2):100-113. doi: 10.2174/1389201019666180925120657.

Two-Year Agility Maintenance Training Slows the Progression of Parkinsonian Symptoms

Tollár J, Nagy F, Kovács N, Hortobágyi T.

Med Sci Sports Exerc. 2019 Feb;51(2):237-245. doi: 10.1249/MSS.0000000000001793.

Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease

Kustrimovic N, Marino F, Cosentino M.

Curr Med Chem. 2019;26(20):3719-3753. doi: 10.2174/0929867325666181009161048.

Dual-Phase 18F-FP-CIT PET in Corticobasal Syndrome

Min JH, Park DG, Yoon JH, An YS.

Clin Nucl Med. 2019 Jan;44(1):e49-e50. doi: 10.1097/RLU.0000000000002355.

Animal Venom Peptides as a Treasure Trove for New Therapeutics Against Neurodegenerative Disorders

Yang X, Wang Y, Wu C, Ling EA.

Curr Med Chem. 2019;26(25):4749-4774. doi: 10.2174/0929867325666181031122438.

Interpreting Genetic Variants: Hints from a Family Cluster of Parkinson's Disease

Cali F, Cantone M, Cosentino FII, Lanza G, Ruggeri G, Chiavetta V, Salluzzo R, Ragalmuto A, Vinci M, Ferri R.

J Parkinsons Dis. 2019;9(1):203-206. doi: 10.3233/JPD-171292.

Balancing Apoptosis and Autophagy for Parkinson's Disease Therapy: Targeting BCL-2

Liu J, Liu W, Yang H.

ACS Chem Neurosci. 2019 Feb 20;10(2):792-802. doi: 10.1021/acschemneuro.8b00356. Epub 2019 Feb 11.

Qualitative Evaluation of the Personal KinetiGraphTM Movement Recording System in a Parkinson's Clinic

Santiago A, Langston JW, Gandhy R, Dhall R, Brillman S, Rees L, Barlow C.

J Parkinsons Dis. 2019;9(1):207-219. doi: 10.3233/JPD-181373.

Graphene-Based Nanomaterials Toxicity in Fish

Dasmahapatra AK, Dasari TPS, Tchounwou PB.

Rev Environ Contam Toxicol. 2019;247:1-58. doi: 10.1007/398_2018_15.

Rhythms of life: circadian disruption and brain disorders across the lifespan

Logan RW, McClung CA.

Nat Rev Neurosci. 2019 Jan;20(1):49-65. doi: 10.1038/s41583-018-0088-y.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias